Skip to Main Content

Paper Details

Association of germline TYK2 variation with lung cancer and non-Hodgkin lymphoma risk.
Int J Cancer
6
2022
Deucravacitinib, JAK, Lung Cancer, TYK2, autoimmune diseases, deucravacitinib, lung cancer, lymphoma, minor allele, non-Hodgkin lymphoma, plaque psoriasis, psoriasis, rs34536443
Author NameAffiliation
Christopher I AmosBaylor College of Medicine
Christopher I AmosBaylor College of Medicine
Rayjean J HungLunenfeld-Tanenbaum Research Institute
Rayjean J HungUniversity of Toronto
George Davey SmithMedical Research Council Integrative Epidemiology Unit, University of Bristol
George Davey SmithBristol Medical School, University of Bristol
George Davey SmithMedical Research Council Integrative Epidemiology Unit, University of Bristol
George Davey SmithBristol Medical School, University of Bristol
  • 1 - 8

Datasets

Release 1.2